Introduction
Acute pancreatitis is one of the most common diseases in gastroenterology. The incidence of acute pancreatitis per 100,000 population ranges from 10 to 46 per year. Two percent of all patients admitted to hospital are diagnosed with acute pancreatitis. Nevertheless even in the 21 st century neither the etiology nor the pathophysiology of the disease are fully understood and causal treatment options are not available. This fact has prompted numerous researchers to study the initial triggering events of acute pancreatitis in order to develop new treatment strategies. Much of our current knowledge regarding the onset of pancreatitis was not gained from studies involving the human pancreas or patients with pancreatitis but from animal or isolated cell models. There are several reasons why these models have been used: 1) the pancreas is a rather inaccessible organ because of its anatomical location in the retroperitoneal space. Unlike the colon or stomach, biopsies of human pancreas are difficult to obtain for ethical and medical reasons. 2) Patients who are admitted to hospital with acute pancreatitis have usually passed through the initial stages of the disease where the triggering early events could have been studied. Particularly the autodigestive process that characterizes this disease has remained a significant impediment for investigations that address initiating pathophysiological events. Therefore, the pathophysiological trigger mechanisms have mostly been studied in animal models of the disease, before randomized placebo controlled trials to evaluate new therapeutic concepts in humans could be initiated. Experimental models are now irreplaceable tools in studying etiological factors, pathophysiology, new diagnostic tools as well as treatment options in acute pancreatitis. The advantages of animal models are the possibility to isolate specific aspects of a complex and varying disease course, the high degree of standardization and reproducibility, and the reduction of the required sample size eliminating variability in the study population.
Animal models can be grouped into invasive in vivo models, non invasive in vivo models and ex vivo models. The mode of onset and development, the disease severity, the extent of inflammation and the associated mortality vary considerably among different models. Here we focus on the model of secretagogue induced pancreatitis.
1a. Secretagogue induced pancreatitis
It is generally believed that the morphologic changes that characterize acute pancreatitis result from digestion of the gland by enzymes that are normally synthesized and secreted by pancreatic acinar cells [1, 2, 3] . Evidence which supports this notion includes the observation that a) the morphological changes of severe pancreatitis resemble those that are typical of digestive necrosis [4] ; b) pancreatic acinar cells synthesize digestive enzymes, which, when activated, lead to digestive necrosis of the gland [5] ; and c) activated digestive enzymes have been detected within the gland during severe pancreatitis [6] . Most of the potentially harmful digestive proteases of acinar cells are normally synthesized and secreted as inactive zymogens and activated physiologically in the duodenum, a process initiated by brushborder enzymes [7] .
As early as in 1895 Mouret et al. reported that excessive cholinergic stimulation is associated with the development of pancreatic injury determined by acinar cell vacuolization and necrosis [8] . Mouret suggested that the activation of trypsin might be actively involved in the development of acute pancreatitis. This hypothesis was in accordance with the work of Hans Chiari who in 1896 proposed that autodigestion as the consequence of premature zymogen activation was the pathological mechanism underlying acute pancreatitis [1] . Subsequently experimental animal models employing cholinergic agonists like carbamylcholine (carbachol), CCK and its analogues as well as scorpion venom were shown to induce pancreatic injury in a time-and dosedependent manner [9, 10, 11, 12, 13] . In rodents CCK plays a major role in regulating exocrine pancreatic secretion after stimulation by food ingestion. However, human pancreatic acinar cells respond only poorly to direct CCK stimulation but are mostly regulated by cholinergic pathways that involve neurogenic CCK stimulation [14] . Lampel and Kern characterised in 1977 the clinical and biochemical pattern of acute interstitial pancreatitis in rats after administration of excessive doses of pancreatic secretagogue and thus established the model of secretagogueinduced pancreatitis [15] . The most prominent clinical characteristic is the development of excessive edema as early as one hour after the onset of the disease [16] . Since that time the model of caerulein (a CCK analogue derived from the Australian tree frog Litoria caerulea, formerly Hyla caerulea) -induced pancreatitis in rodents has been widely used and is one of the best characterized models.
The primary physiological effect of CCK and its analogues on the pancreas is to stimulate protein rich secretion and it has a lesser effect on fluid and electrolyte secretion. Doses of CCK that lead to continued maximal stimulation of enzyme secretion are associated with increased rates of protein synthesis and the movement of newly synthesized proteins through the secretory pathway. The increase in protein synthesis is outpaced by the rate of protein secretion. Thus, following stimulation with maximal secretory doses of caerulein, the enzyme stores of the exocrine pancreas may be reduced by 75% within several hours. Increasing the concentration of CCK by an order of magnitude over the levels that produce maximal secretion is known as supraoptimal stimulation, supramaximal stimulation or hyperstimulation [16] . Compared to maximal stimulation, supramaximal stimulation generates a distinct pancreatic response that includes diminished secretion, accumulation of secretory proteins within the pancreas and pancreatic injury. The route of administration for caerulein that induces acute pancreatitis differs in various rodents as does the severity of the disease [17, 18, 19, 20] . While in rats caerulein can be continuously, intravenously infused either via a polyethylene catheter placed into the external jugular vein or into the tail vein, in mice caerulein is generally injected repeatedly into the peritoneal cavity [21] . The caerulein concentration that results in pancreatic edema, increased serum levels of pancreatic enzymes, inflammation and necrosis ranges between 5 to 10 µg/kg/h in rats and thereby exceeds the maximal secretory doses by 10 to 20 fold. Maximal pancreatic injury occurs after 12 h of continuous infusion but changes can be monitored already 15 minutes after the start of the caerulein infusion and resolve spontaneously after 24 to 48 h. One of the earliest consequences of hyperstimulation is the formation of pancreatic edema. This increase in pancreatic fluid, which occurs within the first hour of caerulein hyperstimulation, is probably the result of several factors: increased vascular permeability [22, 23, 24] , increased hydrostatic pressure from the constriction of small vessels and increased tissue oncotic pressure from the interstitial release of pancreatic enzymes and hydrolytic products. At present, the exact mechanism which leads to the formation of massive edema is not fully understood, but from its time-course a primary signalling effect of caerulein, which does not parallel acinar cell damage, is suggested. Under the conditions of supramaximal caerulein stimulation, secretion of zymogens into the pancreatic duct is virtually abolished; premature zymogen activation can be observed after a sustained intracellular calcium rise and a breakdown of the actin cytoskeleton [25] . These events lead to a systemic inflammatory response syndrome which includes extrapancreatic damage such as pancreatitis related lung injury [26] .
The caerulein model of experimental pancreatitis is now widely used for the analysis of intracellular events in the early phase of pancreatitis. The model offers several advantages: it is noninvasive since no surgical intervention affecting the bile duct or pancreatic duct is necessary, it allows easily controlled grades of injury, it is highly reproducible and it is applicable in several animals species such as mice, rats, hamsters and dogs. The most important limitation of this model is that only a mild, self limited disorder is generated, which limits its use to study the destructive effects of the disease which confer clinical morbidity and mortality [27] [28] [29] [30] [31] [32] [33] . (Figure 1 ). 
Materials

Rodents of any kind:
All rodents (mice, rat) independent of the gender develop pancreatitis upon supramaximal secretagogue stimulation. However, for mice Halangk and co-workers (unpublished data) could show that the extent of pancreatic injury as well as systemic injury differs between in-and outbred mice strains. (Note 1) This can also be observed for the time course of pancreatitis. For rats animals with weight between 200 to 300 g and an approximate age of 12 to 36 weeks should be used. The weight of the mice used for an experiment should usually lie between 20 to 25g and the recommended age is 12 to 36 weeks. For treatment and control groups always the same strain, age and sex of animals should be used to allow for proper comparisons. (Note 2) Animals should allowed to adapt to their experimental environment for at least 3 days as transport stress can render the animals unresponsive to caerulein and they may not develop pancreatitis. Caerulein can be dissolved in PBS or 0.9% NaCl in a concentration of 100µg/ml. This stock solution can be stored at -20°C. Before starting the experiments, the stock solution is diluted in PBS or 0.9% NaCl to a final working concentration which depends on the animal weight and experimental conditions.
Methods 4a. Mice:
After delivery mice weighing 20 to 25 gr should be allowed to adjust to the local conditions of the animal facility for 5 to 7 days. Before the experiment mice should be starved for 12 hours and allowed water ad libitum. (Note 3) Animals are injected intraperitoneally into the right lower quadrant with a 50µg/kg/bw of caerulein dissolved in either PBS or 0.9% saline in a volume of 100 µl. Injections take place in hourly intervals up to 7 injections, but in some cases the protocol differs in times of injections up to 12 h, or over a time period of two days. Severity of pancreatitis depends on the number of injections and a wide range has been published. For the period of injections, it is not needed to give the mice an anesthesia or pain medication. 4b: Analgo-sedation mice:
3c. Rats:
Rats weighing 200 to 300 g are analgo-sedated with ketamine and xylazine. A midline incision at the neck of the rat with a scalpel is performed, followed by blunt preparation of the extra-jugular vein next to the carotic artery. The jugular vein is then ligated in the cranial part to prevent bleeding using Ethicon Mersilene Polyester, 3 Metric 2-0 and a second suture is prepared but not closed in the caudal part of the jugular vein close to the thoracic aperture. (Figure 2) . A small incision to the jugular vein is done and a Portex catheter with a diameter of 58 µm is put into the vein. The catheter is fixed using the suture material described above on the sternocleidomastoideal muscle and the skin is closed using Ethicon Prolene monofil, 1. 3d. Analgo-sedation:
3e. Markers for pancreatitis
To evaluate the severity of pancreatitis, serum activity of lipase and amylase can be measured by a colorimetric assay. Serum lipase activity as well as amylase activity is measured as a kinetic reation over 30 min by use of a photometric plate reader. For both assays kits are available from Roche Hitachi. After induction of pancreatitis, amylase as well as lipase is slightly increased after 1 h up to a maximum increase after 8 h over 3 fold increase of amylase activity and over 5-8 fold increase of lipase activity compared to untreated control animals. An increase of intrapancreatic trypsin activity can be measured by fluorogenic substrates. We use a Rhodamine 110 based bis-peptide substrate (CBZ-Ile-Pro-Arg), in a kinetic assay over 1 h. Pancreatic homogenates were prepared in 100 mM Tris, 5 mM CaCl 2 , pH 8 without any protease inhibitors. It is necessary to work fast and on ice to prevent additional protease activation. The measurement of trypsin activity is a fluorometric assay with excitation at 498 nm and a peak emission at 521 nm. The activity of pancreatic trypsin increases during pancreatitis to about 5 fold increase after 8 h compared to the untreated controls. 
Notes
1. C57BL6 mice (Black 6) give the highest response with regard to protease activity.
2. Unstarved animals do get less severe pancreatitis as zymogen stores may be emptied of proteases after feeding.
3. While caerulein induced pancreatitis in rats is characterized by large vacuoles, mild local pancreatic damage and a mild systemic inflammatory response, lethality can be achieved in mice if repetitive caerulein application is repeated daily over the time period of one week.
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